We are pleased to be joined by a group of voluntary Trustees who govern our work, help determine strategy and provide guidance about how to make living healthy lives easier for all. In addition to quarterly Board meetings, our Trustees also meet regularly for strategy development and finance committee meetings.
**Interested in being a C3 Trustee? We’re recruiting up to 2 new Trustees, particularly individuals with fundraising experience. Applications are due 1 September 2019. Learn more about the role and eligibility requirements.
Zoe set up ZPB Ltd in August 2009 to help private-, public- and third-sector organisations grow reach and influence in the health sector. She directs many of ZPB’s strategic accounts and has led organisations through major crisis situations, helped reposition well-established brands within the health sector and launched several new organisations into the UK market. She specialises in complex stakeholder engagement and management, content and strategic communications.
Prior to ZPB, Zoe was head of marketing and communications at Dr Foster. During her tenure there, the company trebled in size. Zoe regularly speaks on market access, health tech and how to forge successful cross-sector partnerships, and believes passionately in the role of SMEs in stimulating healthcare innovation and the economy. She manages the Cambridge Health Network, is a fellow of the RSA, and a member of The Entrepreneurs’ Organisation (EOUK). Until recently, she was one of the founder members and treasurer of the Emerging Leaders Network.
Zoe is on the strategy development committee for C3’s Board.
Rachel Crossley has spent more than 25 years working at the interface of sustainability, finance and development and now pursues a portfolio career. She focuses particularly on addressing the global nutrition crisis. She started her career at the World Bank in Washington D.C. and then worked for more than 10 years in environmental finance and responsible investment, including roles at ISIS Asset Management and Insight Investment.
Since 2009 she has been an independent consultant, working predominantly as a Senior Advisor to the Access to Nutrition Index. Other clients have included the UN Principles for Responsible Investment, the CDC Group, large food manufacturers, Oxfam and Sense about Science. She has served on a variety of boards and advisory committees, including on the Mayor of London’s Sustainable Development Commission, The Climate Group and the Investment Committee of the Oxfam Enterprise Development Programme.
Rachel is on the strategy development committee for C3’s Board.
Sally Gilding started her professional career at The Law Commission, an independent body created by statue to keep the application of English law under review. From there, she moved to Clifford Chance, a major international law firm, covering corporate finance and capital markets, before entering the banking industry. Following 18 years at Deutsche Bank, Sally established her own independent business, harnessing her experience and expertise in corporate trust and corporate services.
Sally has held numerous board-level appointments including CEO of a Corporate Trust company and also co-chaired the Women in European Business annual conference. She has been active in corporate social responsibility initiatives supporting Inner London schools. Sally has a law degree from the University of London and a BA in psychology and political science from The Australian National University, Canberra.
Sally is chair of C3’s Board.
John is vice-president of Diabetes UK. Since 2007 John has served on various board committees of the International Diabetes Federation and was a non exec director for 6 years until December 2016. Recently he led the spin out of Changing Health from Newcastle University of Changing Health, the first evidence based education and behaviour change toolkit incorporating digital and telephone based personalised coaching for people with chronic diseases and healthcare professionals.
He is also Managing Director of Metapath, award-winning advisors to stakeholders across the health sector on policy, strategy and delivery of care. John has built a number of consumer centric businesses in the UK and across Europe at including GSK, Carphone Warehouse as well as private equity backed turnarounds. John is a chartered accountant and attended Wharton Business School. He has type 1 diabetes and leads an active lifestyle, including participating in international cycling events.
John is chair of the finance committee for C3’s Board.
Harpreet Sood is a physician currently working on national health-care policy and strategy focused on digital health as a Associate Chief Clinical Information Officer for the NHS. Prior to this, Harpreet was Senior Fellow in the office of the chief executive officer at NHS England. He worked on co-designing and scaling up the National Diabetes Prevention Programme, and co-developed the Five Year Forward View (2014).
His passion lies in public health and disease prevention, particularly in how the latest advances in technology, data availability and digital health can improve population and public health on a system level – and he has worked for digital health start-ups, including co-founding Mighty Lungs (a video game to improve children’s adherence of preventative asthma medication). Harpreet holds a Masters in Public Health from Harvard University and has previously been a fellow in administration and health policy at Brigham and Women’s Hospital in Boston. Harpreet sits on the NHS Prevention Board and is Vice Chair for British Computer Society (Health).
Harpreet is on the finance committee for C3’s Board.
Caroline joined Bupa in February 2013 from a long career in the National Health Service. She has a clinical background and brings considerable experience of working at both national (UK) and regional level to enhance and develop leadership capability across health systems. Her position – as director of clinical leadership – recognises that the performance of Bupa as a leading global healthcare company, and the delivery of its ambitious goals enshrined in Bupa 2020, will, in part, be dependent on positioning clinicians at the heart of shaping, influencing and running all elements of the business.
Working in the context of the emerging leadership strategy for Bupa, Caroline’s role is to be the catalyst for enabling connecting and uniting the clinical community to make the biggest possible contribution towards Bupa’s purpose – ‘Longer, Healthier, Happier Lives’.